Alphatec Holdings Inc (ATEC)

Currency in USD
14.97
+0.07(+0.47%)
Closed·
After Hours
14.55-0.42(-2.81%)
·
ATEC Scorecard
Full Analysis
4 analysts have revised their earnings upwards for the upcoming period
ATEC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.9115.32
52 wk Range
4.8815.46
Key Statistics
Prev. Close
14.9
Open
14.98
Day's Range
14.91-15.32
52 wk Range
4.88-15.46
Volume
1.75M
Average Volume (3m)
1.99M
1-Year Change
136.49%
Book Value / Share
0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATEC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.50
Upside
+23.58%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Alphatec Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Alphatec Holdings Inc Company Profile

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Alphatec Holdings Inc Earnings Call Summary for Q2/2025

  • ATEC reports Q2 2025 EPS of $0.02, beating -$0.04 forecast; revenue of $185.54M surpasses $178.8M estimate
  • Company increases full-year revenue guidance to $742M; surgical revenue expected to reach $666M
  • Alphatec achieves first quarter of non-GAAP net income; targets 18% adjusted EBITDA margin by 2027
  • Surgical revenue grows 29% YoY; company prepares for significant robotic system launch in early 2026
  • Stock rises 1.96% in after-hours trading to $10.94, reflecting investor optimism despite initial 1.4% decline
Last Updated: 01/08/2025, 03:56
Read Full Transcript

Compare ATEC to Peers and Sector

Metrics to compare
ATEC
Peers
Sector
Relationship
P/E Ratio
−13.3x−3.5x−0.5x
PEG Ratio
−0.87−0.190.00
Price/Book
93.2x2.9x2.6x
Price / LTM Sales
3.2x3.3x3.3x
Upside (Analyst Target)
34.2%59.4%43.5%
Fair Value Upside
Unlock12.9%6.8%Unlock

Analyst Ratings

10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 18.50
(+23.58% Upside)

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
0.02 / -0.04
Revenue / Forecast
185.54M / 178.80M
EPS Revisions
Last 90 days

ATEC Income Statement

People Also Watch

179.28
ALAB
+4.91%
46.630
ASTS
-2.26%
5.63
FDMT
-2.60%
5.29
REPL
-3.47%
842.50
AXON
-3.27%

FAQ

What Stock Exchange Does Alphatecs Trade On?

Alphatecs is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Alphatecs?

The stock symbol for Alphatecs is "ATEC."

What Is the Alphatecs Market Cap?

As of today, Alphatecs market cap is 2.21B.

What Is Alphatecs's Earnings Per Share (TTM)?

The Alphatecs EPS (TTM) is -1.14.

When Is the Next Alphatecs Earnings Date?

Alphatecs will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is ATEC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Alphatecs Stock Split?

Alphatecs has split 1 times.

How Many Employees Does Alphatecs Have?

Alphatecs has 867 employees.

What is the current trading status of Alphatecs (ATEC)?

As of 09 Aug 2025, Alphatecs (ATEC) is trading at a price of 14.97, with a previous close of 14.90. The stock has fluctuated within a day range of 14.91 to 15.32, while its 52-week range spans from 4.88 to 15.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.